MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS

Aim. To evaluate the prevalence of accomplished goal in laboratory clotting parameters for the anticoagulant therapy in deep vein thrombosis (DVT).Material and methods. The study is performed as one-stage, descriptive, analytic, pharmacoepidemiologic investigation. The material for the study were 20...

Full description

Bibliographic Details
Main Authors: V. I. Petrov, O. V. Shatalova, A. S. Maslakov, A. V. Kushkinova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2014-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/34
_version_ 1797882556670017536
author V. I. Petrov
O. V. Shatalova
A. S. Maslakov
A. V. Kushkinova
author_facet V. I. Petrov
O. V. Shatalova
A. S. Maslakov
A. V. Kushkinova
author_sort V. I. Petrov
collection DOAJ
description Aim. To evaluate the prevalence of accomplished goal in laboratory clotting parameters for the anticoagulant therapy in deep vein thrombosis (DVT).Material and methods. The study is performed as one-stage, descriptive, analytic, pharmacoepidemiologic investigation. The material for the study were 200 case histories of DVT from Volgograd hospitals. The analyzed were: structure of anticoagulant prescription, coagulogrammes with APTT, prothrombin complex and INR.Results. Direct acting anticoagulants were prescribed in 91% cases. High-molecular heparin was used in 84,5% prescriptions, low-molecular heparins — in 6,5%. Monitoring of APTT was done only in 36% patients. The target values of APTT (1,5–2,5 times higher than upper limit) was reached only in 6% cases. Of the indirect anticoagulants warfarin was used in 75,5%. Although laboratory control of warfarin was done in 97% cases, only in 28% of patients INR at discharge was in the range 2,0–3,0.Conclusion. The data witnesses a variety of drawbacks in anticoagulant therapy of DVT patients. High dosages of HMW heparin and warfarin, not enough rigourous control and dosage titration led to the absence of the desired therapeutic diapasone of hypocoagulation.
first_indexed 2024-04-10T03:36:35Z
format Article
id doaj.art-b4312d7aeabe459ba5953c414fd0ff03
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:36:35Z
publishDate 2014-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-b4312d7aeabe459ba5953c414fd0ff032023-03-13T07:23:23Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252014-08-01134545910.15829/1728-8800-2014-4-54-5934MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSISV. I. Petrov0O. V. Shatalova1A. S. Maslakov2A. V. Kushkinova3ГБОУ ВПО Волгоградский государственный медицинский университет Минздрава России, ВолгоградГБОУ ВПО Волгоградский государственный медицинский университет Минздрава России, ВолгоградГБОУ ВПО Волгоградский государственный медицинский университет Минздрава России, ВолгоградГБОУ ВПО Волгоградский государственный медицинский университет Минздрава России, ВолгоградAim. To evaluate the prevalence of accomplished goal in laboratory clotting parameters for the anticoagulant therapy in deep vein thrombosis (DVT).Material and methods. The study is performed as one-stage, descriptive, analytic, pharmacoepidemiologic investigation. The material for the study were 200 case histories of DVT from Volgograd hospitals. The analyzed were: structure of anticoagulant prescription, coagulogrammes with APTT, prothrombin complex and INR.Results. Direct acting anticoagulants were prescribed in 91% cases. High-molecular heparin was used in 84,5% prescriptions, low-molecular heparins — in 6,5%. Monitoring of APTT was done only in 36% patients. The target values of APTT (1,5–2,5 times higher than upper limit) was reached only in 6% cases. Of the indirect anticoagulants warfarin was used in 75,5%. Although laboratory control of warfarin was done in 97% cases, only in 28% of patients INR at discharge was in the range 2,0–3,0.Conclusion. The data witnesses a variety of drawbacks in anticoagulant therapy of DVT patients. High dosages of HMW heparin and warfarin, not enough rigourous control and dosage titration led to the absence of the desired therapeutic diapasone of hypocoagulation.https://cardiovascular.elpub.ru/jour/article/view/34тромбоз глубоких веннефракционированный гепаринактивированное частичное тромбопластиновое времяварфаринмеждународное нормализованное отношение
spellingShingle V. I. Petrov
O. V. Shatalova
A. S. Maslakov
A. V. Kushkinova
MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
Кардиоваскулярная терапия и профилактика
тромбоз глубоких вен
нефракционированный гепарин
активированное частичное тромбопластиновое время
варфарин
международное нормализованное отношение
title MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
title_full MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
title_fullStr MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
title_full_unstemmed MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
title_short MONITORING OF ANTICOAGULANT THERAPY IN PATIENTS WITH DEEP VEIN THROMBOSIS
title_sort monitoring of anticoagulant therapy in patients with deep vein thrombosis
topic тромбоз глубоких вен
нефракционированный гепарин
активированное частичное тромбопластиновое время
варфарин
международное нормализованное отношение
url https://cardiovascular.elpub.ru/jour/article/view/34
work_keys_str_mv AT vipetrov monitoringofanticoagulanttherapyinpatientswithdeepveinthrombosis
AT ovshatalova monitoringofanticoagulanttherapyinpatientswithdeepveinthrombosis
AT asmaslakov monitoringofanticoagulanttherapyinpatientswithdeepveinthrombosis
AT avkushkinova monitoringofanticoagulanttherapyinpatientswithdeepveinthrombosis